Clover Health Investments Corp

Clover Health Investments Corp

Health CareHealth Care Providers
  • Price (USD)2.71
  • Today's Change0.05 / 1.88%
  • Shares traded7.43m
  • 1 Year change-65.39%
  • Beta--
Data delayed at least 15 minutes, as of May 27 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Clover Health Investments, Corp. is a healthcare technology company. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is responsible for coordinating care, managing costs, and providing support to providers and their direct contracting entity (DCE) beneficiaries through the use of Clover Assistant. It offers a software platform called the Clover Assistant, which provides America’s seniors with Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans that are the obvious choice for Medicare-eligible consumers. The Clover Assistant is a technology platform that engages providers and delivers data-driven and personalized care. It operates its MA plans in over nine states.

  • Revenue in USD (TTM)2.15bn
  • Net income in USD-614.65m
  • Incorporated2021
  • Employees680.00
  • Location
    Clover Health Investments Corp3401 Mallory Lane, Suite 210, Suite 320FRANKLIN 37067United StatesUSA
  • Phone+1 (201) 432-2133
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cloverhealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
A10 Networks Inc257.87m98.58m1.20bn590.0012.806.4311.204.641.,069.5030.184.2544.316.8479.1277.7038.234.892.1234.730.006.8710.871.93432.59---4.09--
FinVolution Group - ADR1.41bn374.58m1.20bn4.26k3.330.7589--0.84921.261.264.775.550.5736--6.88331,973.2015.1115.9716.2822.0180.5579.7126.3533.27----0.000.0025.2250.7727.18--13.15--
Core Scientific Inc682.76m-425.74m1.20bn205.00--1.06--1.76-1.39-1.392.173.47----------------43.11---62.36----3.400.5267--802.66--308.57------
SmartRent Inc128.84m-86.09m1.21bn639.0060.892.80--9.420.1020.1020.96892.220.2718----201,621.30-18.16---20.44---11.18---66.82--3.58-6,335.250.00-------1,103,596.00------
Grid Dynamics Holdings Inc243.56m-8.31m1.23bn3.27k--5.30--5.03-0.1307-0.13073.903.451.12--7.0774,390.96-3.81---4.31--40.72---3.41------0.0204--89.86--38.88------
PROS Holdings, Inc.256.54m-87.82m1.23bn1.55k------4.80-1.97-1.975.76-0.28380.5022--4.82166,043.40-17.19-15.71-25.20-26.0058.7659.43-34.23-30.02---12.111.05---0.396610.40-5.49---22.36--
Nextgen Healthcare Inc596.35m1.62m1.24bn2.66k805.163.0228.162.070.02290.02298.806.110.9375--6.02224,613.900.25441.590.35532.1250.4651.830.27131.71--7.940.
Enfusion Inc-100.00bn-100.00bn1.26bn798.00--22.93----------0.4854----------------------------0.00--40.39---7,050.06------
Cerence Inc375.58m32.36m1.26bn1.70k39.641.1920.783.360.80870.80879.2426.870.2214--3.27220,931.201.912.442.102.6974.3170.218.6211.73--4.860.20490.0016.9912.89350.565.617.75--
LivePerson, Inc.491.93m-169.14m1.27bn1.54k--7.03--2.58-2.33-2.336.872.430.4375--4.90319,435.10-15.04-13.64-19.06-18.5964.8571.02-34.38-23.45---4.670.8041--28.1016.08-16.15--30.23--
Alkami Technology Inc163.69m-49.35m1.28bn667.00--3.74--7.82-0.5785-0.57851.923.780.4822--8.62245,407.80-14.54---16.04--55.50---30.15-----21.840.0664--35.68--16.85------
Clover Health Investments Corp2.15bn-614.65m1.28bn680.00--2.61--0.5978-1.47-1.475.001.041.21--2.303,155,956.00-34.66---100.94-------28.64-----64.230.0391-------8,614.16------
Intapp Inc-100.00bn-100.00bn1.29bn749.00--4.83----------4.31----------------------------0.00--14.87---3.98------
Avid Technology, Inc.416.23m47.58m1.34bn1.41k28.78--,248.4018.73-6.8260.57-26.7165.1460.7811.43-4.650.77617.134.25--13.73-4.35274.15-3.01-9.13--
Stem Inc153.04m-41.14m1.36bn213.00--2.16--8.92-0.1297-0.12971.254.100.1698----718,488.30-4.57---5.34--3.27---26.88--1.76--0.4581------10.14------
Data as of May 27 2022. Currency figures normalised to Clover Health Investments Corp's reporting currency: US Dollar USD

Institutional shareholders

18.10%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202225.81m6.82%
Baillie Gifford & Co.as of 31 Mar 20227.79m2.06%
Susquehanna Financial Group LLLPas of 31 Mar 20227.29m1.93%
PNC Bank, NA (Investment Management)as of 31 Mar 20226.36m1.68%
BlackRock Fund Advisorsas of 31 Mar 20225.05m1.34%
Two Sigma Advisers LPas of 31 Mar 20224.75m1.25%
D. E. Shaw & Co. LPas of 31 Mar 20223.87m1.02%
Two Sigma Investments LPas of 31 Mar 20223.21m0.85%
Geode Capital Management LLCas of 31 Mar 20222.37m0.63%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 20222.00m0.53%
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.